Can we prevent inhibitors in mild and moderate factor VIII-deficient patients?

被引：9

作者：

Aledort, LM ^{[1
]}

机构：

[1] Mt Sinai Sch Med, New York, NY 10029 USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷 / 04期

关键词：

D O I：

10.1111/j.1538-7836.2006.01820.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：914 / 914

页数：1

相关论文

共 4 条

[1] INHIBITORS IN HEMOPHILIA PATIENTS - CURRENT STATUS AND MANAGEMENT [J].

ALEDORT, L .

AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (03) :208-217

[2] Factor VIII inhibitors in mild and moderate-severity haemophilia A [J].

Hay, CRM .

HAEMOPHILIA, 1998, 4 (04) :558-563

[3] DESAMINO-D-ARGININE VASOPRESSIN AND BLEEDING-TIME IN VONWILLEBRANDS DISEASE [J].

ISOLA, L ;

FORSTER, A ;

ALEDORT, LM .

ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) :719-720

[4] Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years [J].

Mannucci, PM .

BLOOD, 1997, 90 (07) :2515-2521